Holen Sie sich die Stockscreener-App
5.84
0.69%
0.04
Handel nachbörslich:
5.77
-0.07
-1.20%
Schlusskurs vom Vortag:
$5.80
Offen:
$6.02
24-Stunden-Volumen:
21,522
Relative Volume:
0.97
Marktkapitalisierung:
$11.21M
Einnahmen:
$7.88M
Nettoeinkommen (Verlust:
$-69.20M
KGV:
-3.1913
EPS:
-1.83
Netto-Cashflow:
$-69.73M
1W Leistung:
-5.81%
1M Leistung:
+12.77%
6M Leistung:
-21.08%
1J Leistung:
-53.68%
1-Tages-Spanne:
$5.79
$6.145
1-Wochen-Bereich:
$5.6189
$6.625
52-Wochen-Spanne:
$4.59
$14.36
Bolt Biotherapeutics Inc Stock (BOLT) Company Profile
Firmenname
Bolt Biotherapeutics Inc
Sektor
Branche
Telefon
650-665-9295
Adresse
900 CHESAPEAKE DRIVE, REDWOOD CITY
Vergleichen Sie BOLT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BOLT
Bolt Biotherapeutics Inc
|
5.84 | 11.13M | 7.88M | -69.20M | -69.73M | -1.83 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Bolt Biotherapeutics Inc Stock (BOLT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-01-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-03-02 | Eingeleitet | Guggenheim | Buy |
| 2021-03-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-03-02 | Eingeleitet | SVB Leerink | Outperform |
| 2021-03-02 | Eingeleitet | Stifel | Buy |
Bolt Biotherapeutics Inc Aktie (BOLT) Neueste Nachrichten
Earnings visualization tools for Bolt Biotherapeutics Inc.July 2025 Technicals & Fast Exit and Entry Trade Guides - newser.com
Will Bolt Biotherapeutics Inc. (6LP0) stock issue positive guidance2025 Price Action Summary & AI Driven Price Forecasts - newser.com
Will Bolt Biotherapeutics Inc. stock maintain momentum in 2025Share Buyback & AI Powered Market Trend Analysis - newser.com
Real time scanner hits for Bolt Biotherapeutics Inc. explainedJuly 2025 Sector Moves & Stepwise Trade Execution Plans - newser.com
Published on: 2025-10-13 09:15:08 - newser.com
Is Bolt Biotherapeutics Inc. reversing from oversold territoryQuarterly Trade Summary & Consistent Profit Trading Strategies - newser.com
Can Bolt Biotherapeutics Inc. (6LP0) stock test all time highsWeekly Gains Summary & Verified Technical Signals - newser.com
Candlestick signals on Bolt Biotherapeutics Inc. stock todayRisk Management & Consistent Profit Alerts - newser.com
Regression analysis insights on Bolt Biotherapeutics Inc. performanceTrade Volume Report & Short-Term Trading Opportunity Alerts - newser.com
Bolt Biotherapeutics Inc. stock daily chart insightsTake Profit & Long-Term Capital Growth Strategies - newser.com
Layoff Tracker: Ferring To Cut 500 Employees as Part of Business Model Shift - BioSpace
Bolt Biotherapeutics Inc Stock Analysis and ForecastMarket Liquidity Analysis & Small Budget Trading Portfolio - earlytimes.in
Reversal indicators forming on Bolt Biotherapeutics Inc. stockTrade Analysis Summary & Weekly Market Pulse Updates - newser.com
How Bolt Biotherapeutics Inc. stock reacts to inflationary pressures2025 Risk Factors & Trade Opportunity Analysis Reports - newser.com
Historical volatility pattern of Bolt Biotherapeutics Inc. visualized2025 Institutional Moves & Fast Exit Strategy with Risk Control - newser.com
What analysts say about Bolt Biotherapeutics Inc stockTrading Volume Trends & Free Tap Rapid Wealth - earlytimes.in
Finance Watch: Job Cuts At Takeda, Bolt, Innate, X4 As Strategies Shift - insights.citeline.com
How Bolt Biotherapeutics Inc. (6LP0) stock correlates with oil marketsQuarterly Earnings Summary & Fast Gain Stock Trading Tips - newser.com
Will Bolt Biotherapeutics Inc. (6LP0) stock benefit from Fed rate cutsJuly 2025 Market Mood & Daily Oversold Stock Bounce Ideas - newser.com
Tools to monitor Bolt Biotherapeutics Inc. recovery probability2025 Year in Review & Real-Time Stock Entry Alerts - newser.com
Real time breakdown of Bolt Biotherapeutics Inc. stock performanceQuarterly Trade Report & Daily Oversold Stock Bounce Ideas - newser.com
Will Bolt Biotherapeutics Inc. stock split attract more investors2025 Top Decliners & Intraday High Probability Alerts - newser.com
Is Bolt Biotherapeutics Inc. stock overvalued by current metricsWeekly Market Report & Technical Pattern Based Signals - newser.com
Applying sector rotation models to Bolt Biotherapeutics Inc.Portfolio Profit Report & Growth Oriented Trade Recommendations - newser.com
Published on: 2025-10-05 02:47:09 - newser.com
Custom watchlist performance reports with Bolt Biotherapeutics Inc.Recession Risk & AI Based Buy and Sell Signals - newser.com
Fidus Investment, Rocket Companies And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
Morning Market Movers: ASBP, FICO, ESLA See Big Swings - RTTNews
Morning Market Movers: CIGL, UFG, FRMI, KDK See Big Swings - RTTNews
AMD, Occidental Petroleum, Bolt Biotherapeutics - TradingView
Bolt Biotherapeutics dips after cancer therapy trial delay - TradingView
Why Concorde International Group Shares Are Trading Higher By 55%; Here Are 20 Stocks Moving Premarket - Benzinga
BOLT Updates Phase 1 Study Protocol for BDC-4182 with Strategic Adjustments - GuruFocus
Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027 - GlobeNewswire
Bolt Biotherapeutics to Cut Workforce by 50%; Cancer Drug Trial Data Expected in Q3 of 2026 - MarketScreener
Bolt Biotherapeutics delays clinical data, cuts workforce by half - Investing.com Canada
Finanzdaten der Bolt Biotherapeutics Inc-Aktie (BOLT)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):